Paratek Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 776-800 of 958 matching filings.

Per page
25
Current page
32
8-K File 000-51967

FORM 8-K

Filing date
02 Jul 2012
Reporting date
26 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PATTERSON

Filing date
26 Jun 2012
Reporting date
25 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PATTERSON

Filing date
26 Jun 2012
Reporting date
25 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
26 Jun 2012
Reporting date
25 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KOLLINS FORM 4

Filing date
21 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
21 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81821

13G TSPT 06.08.12

Filing date
08 Jun 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

KOLLINS

Filing date
04 Jun 2012
Reporting date
01 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
04 Jun 2012
Reporting date
01 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
14 May 2012
Reporting date
14 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81821

SC 13G filing

Filing date
04 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-167598

FILED PURSUANT TO RULE 424(B)(5)

Filing date
26 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
26 Apr 2012
Reporting date
26 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-167598

PRELIMINARY PROSPECTUS SUPPLEMENT

Filing date
25 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
25 Apr 2012
Reporting date
25 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51967

DEFINITIVE PROXY STATEMENT

Filing date
24 Apr 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WORTZMAN 4.16.12

Filing date
17 Apr 2012
Reporting date
16 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
10 Apr 2012
Reporting date
04 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
05 Apr 2012
Reporting date
05 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
03 Apr 2012
Reporting date
03 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-180517

FORM S-8

Filing date
02 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81821

FORM SC 13G

Filing date
30 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WORTZMAN OPTION EXERCISE

Filing date
20 Mar 2012
Reporting date
19 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .